DrugDashboards

Quality Choice Moisturizing Relief Eye Drops

Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCl · DEXTRAN 70 .1 g/100mL; TETRAHYDROZOLINE HYDROCHLORIDE .05 g/100mL; POVIDONE 1 g/100mL; POLYETHYLENE GLYCOL 400 1 g/100mL · Solution/ Drops · Ophthalmic · Chain Drug Marketing Association, Inc.

NDC 83324-0191-14 · 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER · OTC MONOGRAPH DRUG · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1520 per mL over the past year. A Class II recall hit this product in the past year (K.C. Pharmaceuticals, Inc). Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Jan 2025Sep 2026$0.152
14 price points · per ML · held since Invalid DateSource: CMS NADAC

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 4 active manufacturers+5
  • Class I/II recall in past 12 months+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline hcl (other) in the next 90 days

sole-source market · price up 6% YoY · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M018
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingMar 3, 2026
    K.C. Pharmaceuticals, IncLack of Assurance of Sterility

Manufacturers of Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCl (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Better Living Brands LLCDEXTRAN 70 100 mg/100mL; POLYETHYLENE GLYCOL 400 1000 mg/100mL; POVIDONE 1000 mg/100mL; TETRAHYDROZOLINE HYDROCHLORIDE 50 mg/100mLJul 15, 2026Sep 2, 2026
Cardinal HealthDEXTRAN 70 100 mg/100mL; POLYETHYLENE GLYCOL 400 1000 mg/100mL; POVIDONE 1000 mg/100mL; TETRAHYDROZOLINE HYDROCHLORIDE 50 mg/100mLJul 15, 2026Sep 2, 2026
Chain Drug Marketing Association, Inc.DEXTRAN 70 .1 g/100mL; TETRAHYDROZOLINE HYDROCHLORIDE .05 g/100mL; POVIDONE 1 g/100mL; POLYETHYLENE GLYCOL 400 1 g/100mLAug 26, 2026Sep 2, 2026
WinCo Foods, LLCDEXTRAN 70 100 mg/100mL; POLYETHYLENE GLYCOL 400 1000 mg/100mL; POVIDONE 1000 mg/100mL; TETRAHYDROZOLINE HYDROCHLORIDE 50 mg/100mLJul 15, 2026Sep 2, 2026
Chain Drug Marketing Association, Inc.DEXTRAN 70 .1 g/100mL; TETRAHYDROZOLINE HYDROCHLORIDE 1 g/100mL; POVIDONE 1 g/100mL; POLYETHYLENE GLYCOL 400 .05 g/100mLJul 22, 2026Aug 19, 2026
Chain Drug Marketing Association, Inc.DEXTRAN 70 .1 g/100mL; POLYETHYLENE GLYCOL 400 1 g/100mL; POVIDONE 1 g/100mL; TETRAHYDROZOLINE HYDROCHLORIDE .05 g/100mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Quality Choice Moisturizing Relief Eye Drops — NDC 83324-0191-14," retrieved September 3, 2026, https://drugdashboards.com/drug/83324019114.

Free to cite with attribution — see how the data is put together.